Home > Financial Ratios > BAFNA PHARMACEUTICALS

BAFNA PHARMACEUTICALS
EV/Core EBITDA

    Back to All Ratios
COMMUNITY POLL
for BAFNA PHARMACEUTICALS
Please provide your vote to see the results

BAFNA PHARMACEUTICALS Last 5 Year EV/Core EBITDA History

[Standalone]

Mar2024Mar2023Mar2022Mar2021Mar2020
   EV/Core EBITDA(x) 13.9611.0922.7930.42-2.27

What is the latest EV/Core EBITDA ratio of BAFNA PHARMACEUTICALS ?

The latest EV/Core EBITDA ratio of BAFNA PHARMACEUTICALS is 13.96 based on Mar2024 Standalone results.
Year EV/Core EBITDA
Mar202413.96
Mar202311.09
Mar202222.79
Mar202130.42
Mar2020-2.27

How is EV/Core EBITDA of BAFNA PHARMACEUTICALS Trending?

Years EV/Core EBITDA % Change
Mar2024 13.96
25.88
Mar2023 11.09
-51.34
Mar2022 22.79
-25.08
Mar2021 30.42
Positive
Mar2020 -2.27 -

Other Financial Ratios of BAFNA PHARMACEUTICALS


Compare EV/Core EBITDA ratio of peers of BAFNA PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
BAFNA PHARMACEUTICALS ₹182.3 Cr 7.3% 5.3% -23.2% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹417,400.0 Cr -0.3% 3.1% 13.4% Stock Analytics
DIVIS LABORATORIES ₹164,844.0 Cr 3.5% 11% 63.5% Stock Analytics
CIPLA ₹121,328.0 Cr 1.6% 2.7% 11.6% Stock Analytics
TORRENT PHARMACEUTICALS ₹110,521.0 Cr 4.1% 4.4% 24.7% Stock Analytics
DR REDDYS LABORATORIES ₹103,043.0 Cr 6.8% 11.3% 3.1% Stock Analytics


BAFNA PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
BAFNA PHARMACEUTICALS

7.3%

5.3%

-23.2%

SENSEX

2.7%

11.8%

14%


You may also like the below Video Courses